Fulcrum Therapeutics Inc

XNAS: FULC

Weak Stock

Download real time

3.06 0.02 (0.66%)

69.79% Fall from 52W High

202.9K XNAS Volume

XNAS 16 Apr, 2025 5:30 PM (EDT)

165.2

Market Cap

Below industry Median

0.6

Beta 1Year

Very Low volatility

Fulcrum Therapeutics Inc - FULC - stock price prediction, stock price target, analyst ratings from 7 analysts

Fulcrum Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -99.7%, and profit growth estimate of -599.3% for FY26, based on top 7 analyst calls.

Forecaster Screeners